» Articles » PMID: 11331595

SMNrp is an Essential Pre-mRNA Splicing Factor Required for the Formation of the Mature Spliceosome

Overview
Journal EMBO J
Date 2001 May 2
PMID 11331595
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

SMNrp, also termed SPF30, has recently been identified in spliceosomes assembled in vitro. We have functionally characterized this protein and show that it is an essential splicing factor. We show that SMNrp is a 17S U2 snRNP-associated protein that appears in the pre-spliceosome (complex A) and the mature spliceosome (complex B) during splicing. Immunodepletion of SMNrp from nuclear extract inhibits the first step of pre-mRNA splicing by preventing the formation of complex B. Re-addition of recombinant SMNrp to immunodepleted extract reconstitutes both spliceosome formation and splicing. Mutations in two domains of SMNrp, although similarly deleterious for splicing, differed in their consequences on U2 snRNP binding, suggesting that SMNrp may also engage in interactions with splicing factors other than the U2 snRNP. In agreement with this, we present evidence for an additional interaction between SMNrp and the [U4/U6.U5] tri-snRNP. A candidate that may mediate this interaction, namely the U4/U6-90 kDa protein, has been identified. We suggest that SMNrp, as a U2 snRNP-associated protein, facilitates the recruitment of the [U4/U6.U5] tri-snRNP to the pre-spliceosome.

Citing Articles

An autoregulatory poison exon in Smndc1 is conserved across kingdoms and influences organism growth.

Belleville A, Thomas J, Tonnies J, Gabel A, Borrero Rossi A, Singh P PLoS Genet. 2024; 20(8):e1011363.

PMID: 39150991 PMC: 11357089. DOI: 10.1371/journal.pgen.1011363.


Pharmacological perturbation of the phase-separating protein SMNDC1.

Enders L, Siklos M, Borggrafe J, Gaussmann S, Koren A, Malik M Nat Commun. 2023; 14(1):4504.

PMID: 37587144 PMC: 10432564. DOI: 10.1038/s41467-023-40124-0.


exRNA-eCLIP intersection analysis reveals a map of extracellular RNA binding proteins and associated RNAs across major human biofluids and carriers.

LaPlante E, Sturchler A, Fullem R, Chen D, Starner A, Esquivel E Cell Genom. 2023; 3(5):100303.

PMID: 37228754 PMC: 10203258. DOI: 10.1016/j.xgen.2023.100303.


Effectors and effects of arginine methylation.

Wang Y, Bedford M Biochem Soc Trans. 2023; 51(2):725-734.

PMID: 37013969 PMC: 10212539. DOI: 10.1042/BST20221147.


The SMN Complex at the Crossroad between RNA Metabolism and Neurodegeneration.

Faravelli I, Riboldi G, Rinchetti P, Lotti F Int J Mol Sci. 2023; 24(3).

PMID: 36768569 PMC: 9917330. DOI: 10.3390/ijms24032247.


References
1.
Buhler D, Raker V, Luhrmann R, Fischer U . Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy. Hum Mol Genet. 1999; 8(13):2351-7. DOI: 10.1093/hmg/8.13.2351. View

2.
Kramer A . The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu Rev Biochem. 1996; 65:367-409. DOI: 10.1146/annurev.bi.65.070196.002055. View

3.
Liu Q, Dreyfuss G . A novel nuclear structure containing the survival of motor neurons protein. EMBO J. 1996; 15(14):3555-65. PMC: 451956. View

4.
Hodges P, Beggs J . RNA splicing. U2 fulfils a commitment. Curr Biol. 1994; 4(3):264-7. DOI: 10.1016/s0960-9822(00)00061-0. View

5.
Liu Q, Fischer U, Wang F, Dreyfuss G . The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell. 1997; 90(6):1013-21. DOI: 10.1016/s0092-8674(00)80367-0. View